About this trial
This study aims to optimize the management of complex biliary stones by identifying predictive factors for SpyGlass lithotripsy failure.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Any adult patient who underwent cholangioscopy-guided lithotripsy for bile duct stones between January 1, 2018, and May 30, 2025
Disqualifiers
Patient who objected to the collection of their data
Trial population
Any adult patient who underwent cholangioscopy-guided lithotripsy for bile duct stones between January 1, 2018, and May 30, 2025
Trial design
Case-only
Retrospective
Treatments tested in this trial
Not listed
Trial groups
Trial outcomes
Primary outcomes
Predictive factors for failure of cholangioscopy lithotripsy in the management of complex bile duct stone
Cholangioscopy-guided lithotripsy failure: defined as stone clearance requiring more than one lithotripsy session or surgical intervention
Sponsors and contacts
Click on the lead sponsor to view all of their trials.